Inventor · disambiguated record
Johnathan M. Lancaster
Also filed as: LANCASTER JOHNATHAN · LANCASTER JOHNATHAN M · LANCASTER JOHNATHAN MARK
8 granted patents·14 pending applications·16 citations·filing 2005–2018
75Inventor score
Files withH LEE MOFFITT CANCER CT & RES7LANCASTER JOHNATHAN M3UNIV DUKE3UNIV SOUTH FLORIDA3LANCASTER JOHNATHAN MARK2
Top patents by PatentIndex Score
22 records- 0186US7655479B2Luminescence characterization of quantum dots conjugated with biomarkers for early cancer detectionUNIV SOUTH FLORIDA·Filed 2005·Granted Feb 2, 2010·16 cites·10 claims
- 0259US2018238890A1Methods and materials for detection, diagnosis and management of ovarian cancerUNIV SOUTH FLORIDA·Filed 2017·Application pending·0 cites
- 0356US9983209B2Method of diagnosing, treating and determining progression and survival of cancer cells using BCL-2 antagonist of cell death (BAD) pathway gene signatureH LEE MOFFITT CANCER CT & RES·Filed 2014·Granted May 29, 2018·0 cites·1 claims
- 0455US8257919B2Micro-RNA profiles associated with endometrial cancer development and response to cisplatin and doxorubicin chemotherapyLANCASTER JOHNATHAN M·Filed 2009·Granted Sep 4, 2012·0 cites·13 claims
- 0555US2018238892A1Method of diagnosing, treating and determining progression and survival of cancer cells using bcl-2 antagonist of cell death (bad) pathway gene signatureH LEE MOFFITT CANCER CT & RES·Filed 2018·Application pending·0 cites
- 0655US2014162891A1Methods and materials for detection, diagnosis and management of ovarian cancerUNIV SOUTH FLORIDA·Filed 2013·Application pending·0 cites
- 0754US2010279957A1Predicting responsiveness to cancer therapeuticsPOTTI ANIL·Filed 2008·Application pending·0 cites
- 0854US2015302140A1In silico identification of cancer molecular signaling pathways and drug candidatesH LEE MOFFITT CANCER CT & RES·Filed 2013·Application pending·0 cites
- 0952US2018207191A1Human cancer micro-rna expression profiles predictive of chemo-responseH LEE MOFFITT CANCER CT & RES·Filed 2017·Application pending·0 cites
- 1051US2010190662A1Methods and materials for detection, diagnosis and management of ovarian cancerSUTPHEN REBECCA·Filed 2008·Application pending·0 cites
- 1151US2013059015A1Human Cancer micro-RNA Expression Profiles Predictive of Chemo-ResponseLANCASTER JOHNATHAN MARK·Filed 2011·Application pending·0 cites
- 1247US2010305058A1Individualized cancer treatmentsUNIV DUKE·Filed 2010·Application pending·0 cites
- 1347US2007172844A1Individualized cancer treatmentsUNIV DUKE·Filed 2006·Application pending·0 cites
- 1446US2009105167A1Predicting responsiveness to cancer therapeuticsUNIV DUKE·Filed 2007·Application pending·0 cites
- 1545US9809858B2O-glycan pathway ovarian cancer signatureH LEE MOFFITT CANCER CT & RES·Filed 2013·Granted Nov 7, 2017·0 cites·9 claims
- 1642US9528982B2Bad phosphorylation determines ovarian cancer chemo-sensitivity and patient survivalH LEE MOFFITT CANCER CT & RES·Filed 2013·Granted Dec 27, 2016·0 cites·15 claims
- 1742US2015154368A1Methods and apparatuses using molecular fingerprints to provide targeted therapeutic strategiesH LEE MOFFITT CANCER CT & RES·Filed 2013·Application pending·0 cites
- 1840US2013011393A1Bad pathway gene signatureLANCASTER JOHNATHAN MARK·Filed 2011·Application pending·0 cites
- 1939US2009186024A1Gene Expression Signatures for Oncogenic Pathway DeregulationNEVINS JOSEPH R·Filed 2006·Application pending·0 cites
- 2037US10982284B2Compositions and methods APC, CREB, and BAD pathways to assess and affect cancerLANCASTER JOHNATHAN M·Filed 2012·Granted Apr 20, 2021·0 cites·2 claims
- 2136US9442116B2Method of predicting chemotherapeutic responsiveness of cancerLANCASTER JOHNATHAN M·Filed 2010·Granted Sep 13, 2016·0 cites·13 claims
- 2232US9063143B2Cancer platinum resistance detection and sensitization methodLANCASTER JOHNATHAN·Filed 2010·Granted Jun 23, 2015·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Johnathan M. Lancaster files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →